Jack Xu, Ph.D, Founder of Elixtide LLC, boasts an impressive 32-year career in the field of drug discovery and drug development. His expertise spans every phase of the peptide therapeutic development lifecycle - from preclinical, clinical to commercial stages, focusing on CMC and GMP. Dr. Xu has a proven track record of success in product development, project/CRO/CDMO management, and regulatory compliance & submissions.

For the past 5 years, he has held senior management positions (VP to SVP) in emerging biotech/pharmaceutical companies, spearheading drug substance (peptides, small molecules and RDCs) and drug product formulation development (oral dosages and injectables).

Prior to this, Dr. Xu accumulated 17 years of experience in various stages of API manufacturing development including peptides, PMOs, oligonucleotides and small molecules, during which he served as Senior Director at Bachem and Principal Scientist at Roche Colorado Co., as well as Production Manager at American Peptide Co. Earlier in his career, Dr. Xu worked in drug discovery as a Peptide Medicinal Chemist at the Institute of Materia Medica, Chinese Academy of Medical Sciences.

Dr. Xu completed two postdoctoral programs at the University of California, Davis, and at the University of Missouri-Kansas City respectively, following the attainment of his Ph.D. degree in Chemistry from Ghent University, Belgium.